GEMOX Combined With Donafenib and Tislelizumab in Advanced Biliary Tract Carcinoma
GEMOX Combined With Donafenib and Tislelizumab in Advanced Biliary Tract Carcinoma
Recruiting · NCT05668884 · Registry updated 2026-01-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| GEMOX Combined With Donafenib and Tislelizumab in Advanced Biliary Tract Carcinoma | Biliary Tract Carcinoma | Recruiting | Phase 2 | 2026-01-14 | NCT05668884 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fudan University | 653 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fudan University Shanghai Cancer Center | Shanghai | China | 4 |